Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Depei Wu

Showing results (121-130 of 579) with videos related to

Pageof 58
Sort By:
Oncotargets and Therapy|April 17, 2019
Delayed remission following sequential infusion of humanized CD19- and CD22-modified CAR-T cells in a patient with relapsed/refractory acute lymphoblastic leukemia and prior exposure to murine-derived CD19-directed CAR-T cellsFei Yang, Jian Zhang, Xinyou Zhang, et al.
European Journal of Haematology|December 21, 2010
Functional polymorphisms in the NBS1 gene and acute lymphoblastic leukemia susceptibility in a Chinese populationLan Jiang, Jianying Liang, Mingjun Jiang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 26, 2015
[The prognostic value of early BCR-ABL transcripts level in 251 patients with chronic myeloid leukemia after treatment with imatinib]Xiebing Bao, Huiying Qiu, Suning Chen, et al.
Clinical Biochemistry|January 15, 2013
RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemiaXiaofei Yang, Jun Qian, Aining Sun, et al.
International Journal of Hematology|February 22, 2008
Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisisYing Wang, Depei Wu, Aining Sun, et al.
Bone Marrow Transplantation|January 28, 2026
Treatment outcome and efficacy of desensitization strategies for immunized-PTR in hematological malignancies before hematopoietic stem cell transplantationYizhou Pan, Yuanling Zuo, Qingya Cui, et al.
Chinese Medical Journal|February 2, 2023
More than two courses of pre-transplant consolidation therapy benefits patients with acute myeloid leukemia in the first complete remission who underwent human leukocyte antigen-matched sibling allografts: a multicenter studyJing Liu, Depei Wu, Qifa Liu, et al.
Microbiology Spectrum|May 27, 2025
Clinical value of metagenomic next-generation sequencing in screening oropharyngeal colonization in patients undergoing allogeneic hematopoietic stem cell transplantation: a prospective observational studyYuqi Zhang, Jianrong Ge, Yuhang Wang, et al.
Journal of Medical Economics|December 13, 2016
The impact of medical insurance coverage and molecular monitoring frequency on outcomes in chronic myeloid leukemia: real-world evidence in ChinaGuangying Sheng, Suning Chen, Ri Zhang, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 18, 2019
Efficacy and safety of prophylaxis with BAY 81-8973 in Chinese patients with severe haemophilia A enrolled in the LEOPOLD II trialRenchi Yang, Jing Sun, Yongqiang Zhao, et al.
Pageof 58

Showing results (121-130 of 579) with videos related to

Sort By:
Pageof 58
Oncotargets and Therapy|April 17, 2019
Delayed remission following sequential infusion of humanized CD19- and CD22-modified CAR-T cells in a patient with relapsed/refractory acute lymphoblastic leukemia and prior exposure to murine-derived CD19-directed CAR-T cellsFei Yang, Jian Zhang, Xinyou Zhang, et al.
European Journal of Haematology|December 21, 2010
Functional polymorphisms in the NBS1 gene and acute lymphoblastic leukemia susceptibility in a Chinese populationLan Jiang, Jianying Liang, Mingjun Jiang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 26, 2015
[The prognostic value of early BCR-ABL transcripts level in 251 patients with chronic myeloid leukemia after treatment with imatinib]Xiebing Bao, Huiying Qiu, Suning Chen, et al.
Clinical Biochemistry|January 15, 2013
RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemiaXiaofei Yang, Jun Qian, Aining Sun, et al.
International Journal of Hematology|February 22, 2008
Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisisYing Wang, Depei Wu, Aining Sun, et al.
Bone Marrow Transplantation|January 28, 2026
Treatment outcome and efficacy of desensitization strategies for immunized-PTR in hematological malignancies before hematopoietic stem cell transplantationYizhou Pan, Yuanling Zuo, Qingya Cui, et al.
Chinese Medical Journal|February 2, 2023
More than two courses of pre-transplant consolidation therapy benefits patients with acute myeloid leukemia in the first complete remission who underwent human leukocyte antigen-matched sibling allografts: a multicenter studyJing Liu, Depei Wu, Qifa Liu, et al.
Microbiology Spectrum|May 27, 2025
Clinical value of metagenomic next-generation sequencing in screening oropharyngeal colonization in patients undergoing allogeneic hematopoietic stem cell transplantation: a prospective observational studyYuqi Zhang, Jianrong Ge, Yuhang Wang, et al.
Journal of Medical Economics|December 13, 2016
The impact of medical insurance coverage and molecular monitoring frequency on outcomes in chronic myeloid leukemia: real-world evidence in ChinaGuangying Sheng, Suning Chen, Ri Zhang, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 18, 2019
Efficacy and safety of prophylaxis with BAY 81-8973 in Chinese patients with severe haemophilia A enrolled in the LEOPOLD II trialRenchi Yang, Jing Sun, Yongqiang Zhao, et al.
Pageof 58